Comparative Efficacy and Safety of Ultra-Long-Acting, Long-Acting, Intermediate-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: a Systematic Review and Network Meta-Analysis.
Andrea C TriccoHuda M AshoorJesmin AntonyZachary BouckMyanca RodriguesBa' PhamPaul A KhanVera NincicNazia DarveshFatemeh YazdiMarco GhassemiJohn D IvoryAreti Angeliki VeronikiCatherine H YuLorenzo MojaSharon E StrausPublished in: Journal of general internal medicine (2021)
CRD42017077051.